TEPMETKO Film-coated tablet Ref.[49534] Active ingredients: Tepotinib

Source: FDA, National Drug Code (US)  Revision Year: 2021 

Product description

Tepotinib is a kinase inhibitor. TEPMETKO (tepotinib) tablets for oral use are formulated with tepotinib hydrochloride hydrate. The chemical name for tepotinib hydrochloride hydrate is 3-{1-[(3-{5-[(1-methylpiperidin-4-yl)methoxy]pyrimidin-2-yl}phenyl)methyl]-6-oxo-1,6-dihydropyridazin-3-yl}benzonitrile hydrochloride hydrate. The molecular formula is C29H28N6O2∙HCl∙H2O and the molecular weight is 547.05 g/mol for tepotinib hydrochloride hydrate and 492.58 g/mol for tepotinib (free base).

The chemical structure is shown below:

Tepotinib hydrochloride hydrate is a white to off-white powder with a pKa of 9.5.

TEPMETKO is supplied as film-coated tablets containing 225 mg of tepotinib (equivalent to 250 mg tepotinib hydrochloride hydrate). Inactive ingredients in the tablet core are mannitol, microcrystalline cellulose, crospovidone, magnesium stearate, and colloidal silicon dioxide. The tablet coating consists of hypromellose, titanium dioxide, lactose monohydrate, polyethylene glycol, triacetin, and red iron oxides.

Dosage Forms and Strengths

Tablets: 225 mg, white-pink, oval, biconvex film-coated tablets with embossment “M” on one side and plain on the other side.

How Supplied

TEPMETKO (tepotinib) tablets: 225 mg tepotinib, white-pink, oval, biconvex film-coated tablet with embossment “M” on one side and plain on the other side.

NDC number Size
44087-5000-3 Box of 30 tablets: 3 blister cards each containing 10 tablets
44087-5000-6 Box of 60 tablets: 6 blister cards each containing 10 tablets

The blister cards consist of a child-resistant blister foil.

Manufactured for: EMD Serono, Inc., Rockland, MA 02370, U.S.A.

TEPMETKO is a trademark of Merck KGaA, Darmstadt, Germany

Drugs

Drug Countries
TEPMETKO Austria, Brazil, Estonia, Finland, Croatia, Israel, Italy, Japan, Lithuania, Poland, United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.